Search
for
Sort by
Research 61–90 of 389
- Advances in the management of alopecia areata
- Oral Manifestations of Hematologic and Nutritional Diseases
- Alopecia areata update
- Plasmacytoid dendritic cells in alopecia areata: missing link?
- Cinnamomi Cortex (Cinnamomum verum) Suppresses Testosterone-induced Benign Prostatic Hyperplasia by Regulating 5α-reductase
- Toward a Diagnostic Score in Cushing's Syndrome
- Transient mitochondrial DNA double strand breaks in mice cause accelerated aging phenotypes in a ROS-dependent but p53/p21-independent manner
- Recent positive selection of a human androgen receptor/ectodysplasin A2 receptor haplotype and its relationship to male pattern baldness
- Anabolic-androgenic steroids and cardiovascular risk
- Prediction of male-pattern baldness from genotypes
- Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Iron deficiency and diffuse nonscarring scalp alopecia in women: More pieces to the puzzle
- MicroRNA in skin diseases
- Ancient Genomes Reveal the Evolutionary History and Origin of Cashmere-Producing Goats in China
- Prospective metabolic evaluation of 150 consecutive patients who underwent gastric exclusion
- Post-finasteride syndrome: An emerging clinical problem
- Safety profile of human papilloma virus vaccines: an analysis of the US Vaccine Adverse Event Reporting System from 2007 to 2017
- Inhibition of Inflammatory Gene Expression in Keratinocytes Using a Composition Containing Carnitine, Thioctic Acid and Saw Palmetto Extract
- Clinical Case Seminar: Postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis
- Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction
- Finasteride, not tamsulosin, increases severity of erectile dysfunction and decreases testosterone levels in men with benign prostatic hyperplasia
- Adverse cutaneous reactions to chemotherapeutic agents and cytokine therapy
- Persistent Erectile Dysfunction after Discontinuation of 5-Alpha Reductase Inhibitor Therapy in Rats Depending on the Duration of Treatment
- The treatment of alopecia areata
- Risk Factors for Male Lower Urinary Tract Symptoms: The Role of Metabolic Syndrome and Androgenetic Alopecia in a Latin American Population
- 5-Alpha-Reductase Inhibitors and Combination Therapy
- Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs
- Development of finasteride/PHBV@polyvinyl alcohol/chitosan reservoir-type microspheres as a potential embolic agent: from <i>in vitro</i> evaluation to animal study
- Development of a Doxazosin and Finasteride Transdermal System for Combination Therapy of Benign Prostatic Hyperplasia